SEC Form 4 · accession 0000899243-18-017432
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Wolter
Officer — Chief Financial Officer
Period of report
Jun 15, 2018
Accepted (ET)
Jun 20, 2018 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $2.33 | Jun 15, 2018 | A | 24,000 | A | — | Jun 15, 2028 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1Twenty-five percent (25%) of the Shares subject to the Option shall vest three (3) months after the Vesting Commencement Date (June 1, 2018), and one-third (1/3) of the Shares subject to the Option shall vest every three months thereafter on the same day of the month as the Vesting Commencement Date, subject to Participant continuing to be a Service Provider through each such date.